Bold Solutions
to Challenge AFib

EP Bold Solutions

AFib is a growing crisis in Electrophysiology (EP). This condition affects
more than 37 million people.1 We create bold solutions to challenge
AFib. This is a suite technology that boldly redefines the EP Lab.
Clinical support that elevates your practice to meet today’s challenges.
It is a partnership to drive impact and grow the EP community.

     FROM 37 MILLION      
   TODAY, TO MORE
     THAN
60 MILLION
     BY
2050

INNOVATE
 

Technology that boldly
redefines the EP Lab

Innovate

ELEVATE


 Clinical support that elevates your
practice to meet today's challenges

Elevate

IMPACT


Partnerships that drive
impact for the EP community  

Impact

ONLY ABBOTT OFFERS A HOLISTIC EP PORTFOLIO

 

References

  1. Go A, Hylek E, Phillips K, Chang Y, et al. Prevalence of Diagnosed Atrial Fibrillation in Adults: National implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors In Atrial Fibrillation (ATRIA) Study. JAMA. 2001; 285(18): 2370-5. https://jamanetwork.com/journals/jama/fullarticle/193807

MAT-2208730 v2.0